Biomarker discovery in plasma of breast cancer patients using microspot immunoassays

被引：0
|
作者：
Sonntag, J. [1 ]
Joecker, A. [1 ]
Schneeweiss, A. [2 ]
Wiemann, S. [1 ]
Korf, U. [1 ]
机构：
[1] German Canc Res Ctr, Div Mol Genome Anal, D-6900 Heidelberg, Germany
[2] Univ Heidelberg, Dept Gynecol & Obstet, Heidelberg, Germany
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 05期
关键词：
D O I：
10.1016/S1359-6349(10)70987-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
180
引用
收藏
页码：47 / 47
页数：1
相关论文
共 50 条
  • [41] PAPAyA: a platform for breast cancer biomarker signature discovery, evaluation and assessment
    Angel Janevski
    Sitharthan Kamalakaran
    Nilanjana Banerjee
    Vinay Varadan
    Nevenka Dimitrova
    BMC Bioinformatics, 10
  • [42] Pleiotrophin as a potential biomarker in breast cancer patients
    Ma, Jiequn
    Kong, Ying
    Nan, Haocheng
    Qu, Shengyang
    Fu, Xiao
    Jiang, Lili
    Wang, Wenjuan
    Guo, Hui
    Zhao, Shounian
    He, Jianjun
    Nan, Kejun
    CLINICA CHIMICA ACTA, 2017, 466 : 6 - 12
  • [43] An Integrated Quantitative Proteomics Workflow for Cancer Biomarker Discovery and Validation in Plasma
    Kumar, Vipin
    Ray, Sandipan
    Ghantasala, Saicharan
    Srivastava, Sanjeeva
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [44] Plasma Membrane Proteomics and Its Application in Clinical Cancer Biomarker Discovery
    Leth-Larsen, Rikke
    Lund, Rikke R.
    Ditzel, Henrik J.
    MOLECULAR & CELLULAR PROTEOMICS, 2010, 9 (07) : 1369 - 1382
  • [45] Integrating Deep Learning and SHAP for Breast Cancer Classification and Biomarker Discovery Using Gene Expression Data
    Aliouane, Salah Eddine
    Chehili, Hamza
    Boulahrouf, Khaled
    Abdelaziz, Aya
    Khlifa, Nawres
    Hamidechi, Mohamed Abdelhafid
    IEEE ACCESS, 2025, 13 : 49693 - 49709
  • [46] Biomarker Discovery and Evaluation of Response to Anti-Cancer Therapeutics in Breast Cancer Using a Novel Nanofluidic Immunoassay Platform
    Iacovides, D. C.
    Johnson, A. B.
    Boge, A.
    Nguyen, U.
    Shah, S.
    Gentalen, E.
    Gray, J. W.
    CANCER RESEARCH, 2009, 69 (24) : 703S - 703S
  • [47] Plasma Thioredoxin Reductase as a Potential Diagnostic Biomarker for Breast Cancer
    Hu, Yixuan
    Zhu, Yinxing
    Shi, Junfeng
    Wei, Xiaowei
    Tang, Cuiju
    Guan, Xiaoxiang
    Zhang, Wenwen
    CLINICAL BREAST CANCER, 2024, 24 (06)
  • [48] Role of plasma osteopontin as a biomarker in locally advanced breast cancer
    Anborgh, Pieter H.
    Caria, Laura B. R.
    Chambers, Ann F.
    Tuck, Alan B.
    Stitt, Larry W.
    Brackstone, Muriel
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2015, 7 (04): : 723 - 732
  • [49] A plasma biomarker panel of microRNAs for early breast cancer diagnosis
    Siddique, S.
    Khan, D. A.
    Aamir, M.
    Khan, J. S.
    Matloob, N.
    Butt, A. M.
    ANNALS OF ONCOLOGY, 2020, 31 : S313 - S313
  • [50] Revisiting biomarker discovery by plasma proteomics
    Geyer, Philipp E.
    Holdt, Lesca M.
    Teupser, Daniel
    Mann, Matthias
    MOLECULAR SYSTEMS BIOLOGY, 2017, 13 (09)
12345